Disc Medicine, Inc.·4

Jan 21, 6:55 PM ET

Khara Rahul 4

Research Summary

AI-generated summary

Updated

Disc Medicine (IRON) CLO Rahul Khara Exercises Options, Sells Shares

What Happened

  • Rahul Khara, Chief Legal Officer of Disc Medicine (IRON), exercised stock options and sold shares on January 20, 2026. She exercised 1,000 option shares at $13.50 per share (cost $13,500) and sold 1,000 shares in an open-market transaction at $69.74 per share (proceeds $69,740). The filing also reports a separate derivative disposition of 1,000 shares at $0 (reported as an M-coded derivative transaction).

Key Details

  • Transaction date: 2026-01-20.
  • Exercise: 1,000 shares exercised at $13.50 (total cost $13,500).
  • Open-market sale: 1,000 shares sold at $69.74 (total proceeds $69,740).
  • Additional derivative disposition: 1,000 shares at $0 reported (details not specified in the summary).
  • Plan/footnote: Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted Sept 23, 2025 (F1).
  • Vesting note: Underlying option vests in 48 equal monthly installments following Dec 29, 2022 (F2).
  • Shares owned after the reported transactions: not specified in the provided excerpt.
  • Filing timeliness: report filed Jan 21, 2026 for transactions on Jan 20, 2026 (appears timely).

Context

  • The insider exercised options and sold shares the same day. Same-day sales following an exercise are commonly used to cover the exercise cost and taxes (a cashless-style practice), but the filing does not state the specific purpose. The 10b5-1 plan note indicates the sale was executed under a pre-established trading plan.